Blend Therapeutics, Inc.
Blend is discovering and developing integrative combination medicines with the unprecedented ability to precisely control each agent’s therapeutic action in concert. Using our proprietary Maestro™ platform, we design and integrate drugs to target distinct disease pathways with optimal efficacy and safety. Blend was founded by three leaders in the fields of chemistry and nanomedicine from MIT and Harvard Medical School: Dr. Robert Langer and Dr. Stephen Lippard of MIT, and Dr. Omid Farokhzad of Harvard Medical School.
Blend is committed to hiring the best scientists and empowering them to reach their full potential. We invite you to join our team if you are passionate about developing integrated, mechanistically engineered combination medicines that will significantly improve the quality of patients’ lives.